In this Breastcancer.org podcast, Brian Wojciechowski, M.D., Breastcancer.org’s medical adviser, explains a study published in January 2016 suggesting that chemotherapy for breast cancer may increase the risk of common infections.

Listen to the podcast to hear Dr. Wojciechowski talk about:

Cristina Nixon is a licensed certified genetic counselor with the Cancer Risk Assessment and Genetics Program at Main Line Health in Pennsylvania. In addition to counseling patients, she also assists with research, including, most recently, a study looking at multi-gene panels in BRCA1/BRCA2 positive families. Cristina also has completed the City of Hope’s intensive course in cancer risk assessment.

This is part one of three-part podcast on genetics and breast cancer with Cristina.

Listen to this podcast to hear her explain:

Listen to part 2 of the series.

Listen to part 3 of the series.

Cristina Nixon is a licensed certified genetic counselor with the Cancer Risk Assessment and Genetics Program at Main Line Health in Pennsylvania. In addition to counseling patients, she also assists with research, including most recently a study looking at multi-gene panels in BRCA1/BRCA2-positive families. Cristina also has completed the City of Hope’s intensive course in cancer risk assessment.

This is part two of three-part podcast on genetics and breast cancer with Cristina.

Listen to this podcast to hear her explain:

Listen to part 1 of the series.

Listen to part 3 of the series.

Cristina Nixon is a licensed certified genetic counselor with the Cancer Risk Assessment and Genetics Program at Main Line Health in Pennsylvania. In addition to counseling patients, she also assists with research, including most recently a study looking at multi-gene panels in BRCA1/BRCA2-positive families. Cristina also has completed the City of Hope’s intensive course in cancer risk assessment.

This is part three of three-part podcast on genetics and breast cancer with Cristina.

Listen to this podcast to hear her explain:

Listen to part 1 of the series.

Listen to part 2 of the series.

Dr. Alan Stolier is a surgeon at the Center for Restorative Breast Surgery in New Orleans. He has more than 35 years of experience in surgical oncology. He specializes in the surgical treatment of breast cancer and is a pioneer in the development of nipple-sparing mastectomy. Dr. Stolier also focuses on breast cancer genetics and the associated care of women who have a BRCA gene mutation.

Listen to the podcast to hear Dr. Stolier talk about:

Listen to part 2 of the series.

Dr. Alan Stolier is a surgeon at the Center for Restorative Breast Surgery in New Orleans. He has more than 35 years of experience in surgical oncology. He specializes in the surgical treatment of breast cancer and is a pioneer in the development of nipple-sparing mastectomy. Dr. Stolier also focuses on breast cancer genetics and the associated care of women who have a BRCA gene mutation.

Listen to the podcast to hear Dr. Stolier talk about:

Listen to part 1 of the series.

Lorell Hornbrook has a strong family history of breast cancer: Both her older sister and her father were diagnosed with breast cancer. Her father died at age 75 from treatment complications, a year after he was diagnosed. In 2014, at age 48, Lorell decided to have genetic testing to see if she had a gene mutation that dramatically increased her risk for breast cancer. When her test results came back positive for a BRCA2 mutation, Lorell had already decided what she would do: a double prophylactic mastectomy and reconstruction using tissue from her tummy area.

Lorell is one of three women whose stories are featured in the Breastcancer.org video series on genetic testing, prophylactic surgery, and reconstruction.

Listen to the podcast to hear Lorell talk about:

Kerry Osmond was 10 when her mother was diagnosed with breast cancer in 1990. When it became available, genetic testing for a mutation that raises the risk of breast cancer was strongly recommended for Kerry’s mom — in 2010 her mother tested positive for a BRCA2 mutation. Kerry knew that meant she had a 50-50 chance of having the same mutation. In 2012, she decided to have genetic testing and learned that she, too, had a BRCA2 mutation. She decided to have a double prophylactic mastectomy and reconstruction using tissue from her hip area.

Kerry is one of three women whose stories are featured in the Breastcancer.org video series on genetic testing, prophylactic surgery, and reconstruction. Kerry’s younger sister, Mandi, also tested positive for a BRCA2 mutation and is also in the video series.

Listen to the podcast to hear Kerry talk about:

Mandi Seifert was 3 when her mother was diagnosed with breast cancer in 1990. When it became available, genetic testing for a mutation that raises the risk of breast cancer was strongly recommended for Mandi’s mom — in 2010 her mother tested positive for a BRCA2 mutation. Mandi knew that meant she had a 50-50 chance of having the same mutation. In 2013, she decided to have genetic testing and learned that she, too, had a BRCA2 mutation. She decided to have a double prophylactic mastectomy and reconstruction using tissue from her tummy area.

Mandi is one of three women whose stories are featured in the Breastcancer.org video series on genetic testing, prophylactic surgery, and reconstruction. Mandi’s older sister, Kerry, also tested positive for a BRCA2 mutation and is also in the video series.

Listen to the podcast to hear Mandi discuss: